InVivo Therapeutics Holdings And Subsidiary Filed For Chapter 11 Bankruptcy In Delaware But Plan To Continue Operating Under Court Supervision As A Debtor-In-Possession.
Portfolio Pulse from Benzinga Newsdesk
InVivo Therapeutics Holdings and its subsidiary have filed for Chapter 11 bankruptcy in Delaware, intending to continue operations under court supervision as a debtor-in-possession, according to an SEC filing.
February 01, 2024 | 1:29 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
InVivo Therapeutics Holdings has filed for Chapter 11 bankruptcy but plans to continue its operations under court supervision.
Filing for Chapter 11 bankruptcy typically has a negative impact on a company's stock price due to the uncertainty and financial distress it represents. However, the intention to continue operations might mitigate some negative perceptions. The direct mention of NVIV in the context of bankruptcy filing makes this news highly relevant and important for investors, influencing the stock's short-term performance negatively.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100